AJIPHASE News, Researches, Clinical Trials and Articles

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Powered by Hostinger

Latest Articles

7 Breakthrough DMD Research Programs That Could Transform Duchenne Treatment in 2026

Editorials July 22, 2026 6

The landscape of Duchenne muscular dystrophy (DMD) research is...

Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen, an Exon 51 Skipping Therapy for Duchenne Muscular Dystrophy (DMD)

Press Releases July 20, 2026 0

Families affected by Duchenne muscular dystrophy (DMD) received encouraging...

Santhera Expands Biomedica Agreement to Extend AGAMREE (Vamorolone) Distribution Across Central Asia and the Caucasus

Press Releases July 13, 2026 0

Santhera today announces an expansion of its exclusive distribution...

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Therapies December 26, 2024 4

A genetic condition known as Duchenne muscular dystrophy (DMD)...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 9

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 2

The duchenne muscular dystrophy treatment cost has become one...

Duchenne MD

Genetic

Care Guidelines

Health Guidelines

AJIPHASE

Must Read

Calcium in Duchenne Muscular Dystrophy: Mechanisms, Risks, and Treatment Insights

Why CK, AST, and ALT Data Matter More Than Videos in Duchenne Gene Therapy

Does My Child Have Duchenne Muscular Dystrophy (DMD)?